
Last updated: 13 days ago
AstraZeneca PLC: SEC Filing Unveils Strategic U.S. Growth Plans & Financial Success
Explore AstraZeneca's SEC Form 6-K insights on revenue growth, U.S. market strategies, and a proposed NYSE listing. Strong buy recommendation for investors eyeing future gains.